Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alain Cassidanius"'
Autor:
Isabelle Tenaud, François Romagné, Catherine Laplace, Sylvain Bercegeay, Alain Cassidanius, Soraya Saiagh, Brigitte Dréno, Samuel Salot, Jérôme Tiollier
Publikováno v:
Journal of Immunological Methods. 326:63-75
gamma9delta2 T lymphocytes are non-conventional lymphocytes presenting a direct cytotoxic effect against a broad range of tumour targets. These cells also secrete inflammatory cytokines that can boost the other components of the immune system. In con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b314435547fc915a9d97a8df4a32c507
https://doi.org/10.1016/j.jim.2007.07.010
https://doi.org/10.1016/j.jim.2007.07.010
Autor:
Jean-Michel Nguyen, Marie Christine Pandolfino, Amir Khammari, Brigitte Dréno, Philippe Lemarre, Francine Jotereau, Marie Helene Tessier, Alain Cassidanius, Sylvain Bercegeay, Nathalie Labarrière, Sylviane Billaudel
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2002, 51 (10), pp.539-546. ⟨10.1007/s00262-002-0315-1⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2002, 51 (10), pp.539-546. ⟨10.1007/s00262-002-0315-1⟩
International audience; The aim of this study was to demonstrate the interest of using tumor-infiltrating lymphocytes (TIL) as adjuvant therapy for stage III (regional lymph nodes) melanoma. After lymph node excision, patients without any detectable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b88c75e3e9c6b442c5889ea26fc094e3
https://doi.org/10.1007/s00262-002-0315-1
https://doi.org/10.1007/s00262-002-0315-1
Autor:
Amir Khammari, Sylvain Bercegeay, Marie Christine Pandolfino, Jean-Michel Nguyen, Philippe Lemarre, Christelle Volteau, Francine Jotereau, Brigitte Dréno, Alain Cassidanius, Gaëlle Quéreux, Nathalie Labarrière, Anabelle Brocard
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2007, 56 (11), pp.1853-1860. ⟨10.1007/s00262-007-0340-1⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2007, 56 (11), pp.1853-1860. ⟨10.1007/s00262-007-0340-1⟩
The first analysis of our clinical trial on interest of using tumor-infiltrating lymphocytes (TIL) as adjuvant therapy for stage III (regional lymph nodes) melanoma was published in 2002 [5]. The aim of this paper is to update clinical results of 7 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33eadccdc2a475e72f00bd52dfea4d65
https://www.hal.inserm.fr/inserm-02482045
https://www.hal.inserm.fr/inserm-02482045
Autor:
Samuel, Salot, Catherine, Laplace, Soraya, Saïagh, Sylvain, Bercegeay, Isabelle, Tenaud, Alain, Cassidanius, François, Romagne, Brigitte, Dreno, Jérôme, Tiollier
Publikováno v:
Journal of immunological methods. 326(1-2)
gamma9delta2 T lymphocytes are non-conventional lymphocytes presenting a direct cytotoxic effect against a broad range of tumour targets. These cells also secrete inflammatory cytokines that can boost the other components of the immune system. In con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d909635e718c2ee3e611a000debe149b
https://pubmed.ncbi.nlm.nih.gov/17716681
https://pubmed.ncbi.nlm.nih.gov/17716681